PhenomeX Beheer

Beheer criteriumcontroles 1/4

De CEO PhenomeX is Siddhartha Kadia, benoemd in Mar2022, heeft een ambtstermijn van 1.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 10.10M, bestaande uit 5.6% salaris en 94.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.65% van de aandelen van het bedrijf, ter waarde $ 644.07K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.2 jaar en 3.3 jaar.

Belangrijke informatie

Siddhartha Kadia

Algemeen directeur

US$10.1m

Totale compensatie

Percentage CEO-salaris	5.6%
Dienstverband CEO	1.6yrs
Eigendom CEO	0.6%
Management gemiddelde ambtstermijn	1.2yrs
Gemiddelde ambtstermijn bestuur	3.3yrs

Recente managementupdates

Recent updates

Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

May 16

PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Apr 17

Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Aug 15

Berkeley Lights: Optofluidic Technology Presents Strong Upside, May Redefine Therapeutic Development

Jun 09

Berkeley Lights Q1 2021 Earnings Preview

May 10

Analyse CEO-vergoeding

Hoe is Siddhartha Kadia's beloning veranderd ten opzichte van PhenomeX's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Jun 30 2023	n/a	n/a	-US$125m
Mar 31 2023	n/a	n/a	-US$100m
Dec 31 2022	US$10m	US$567k	-US$98m
Sep 30 2022	n/a	n/a	-US$86m
Jun 30 2022	n/a	n/a	-US$85m
Mar 31 2022	n/a	n/a	-US$78m
Dec 31 2021	US$309k	n/a	-US$72m

Compensatie versus markt: De totale vergoeding ($USD 10.10M ) Siddhartha } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 649.07K ).

Compensatie versus inkomsten: De vergoeding van Siddhartha is gestegen terwijl het bedrijf verliesgevend is.

CEO

Siddhartha Kadia (53 yo)

1.6yrs

Tenure

US$10,096,450

Compensatie

Dr. Siddhartha Chandrakant Kadia, Ph D., M.S (Biomedical Engineering) & BE (Electronics and Telecommunication), has been Director at Berkeley Lights, Inc. since September 07, 2021 and serves as its Chief E...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Siddhartha Kadia	CEO & Director	1.6yrs	US$10.10m	0.65% $ 644.1k
Mehul Joshi	CFO & Principal Accounting Officer	1.3yrs	US$3.02m	0.065% $ 64.9k
Scott Chaplin	Chief Legal Officer & Corporate Secretary	1.1yrs	US$1.95m	0.020% $ 19.9k
Eric Hobbs	Executive Vice President of Integrations & Business Transformation	less than a year	US$1.78m	0.24% $ 242.6k
Suzanne Hatcher	Vice President of Communications & Investor Relations	no data	geen gegevens	geen gegevens
Lucas Vitale	Chief Human Resources Officer	1.5yrs	geen gegevens	geen gegevens
Rolando Brawer	Chief Business Officer	less than a year	geen gegevens	geen gegevens

1.2yrs

Gemiddelde duur

49.5yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van CELL wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.2 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Siddhartha Kadia	CEO & Director	2.1yrs	US$10.10m	0.65% $ 644.1k
Dan Maydan	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Igor Khandros	Co-Founder & Independent Director	12.8yrs	US$225.01k	9.02% $ 9.0m
Elizabeth Nelson	Independent Director	4.1yrs	US$247.01k	0.076% $ 75.8k
Gregory Lucier	Independent Chairman of the Board	3.3yrs	US$370.09k	0.14% $ 135.8k
James E. Rothman	Chairman of Scientific Advisory Board	no data	US$345.01k	0.14% $ 144.0k
Ming Wu	Co-Founder & Member of Scientific Advisory Board	3.3yrs	geen gegevens	geen gegevens
John Chiminski	Independent Director	2.4yrs	US$237.51k	0.041% $ 40.8k
Eric Schadt	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Deepak Srivastava	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens
Jessica Hopfield	Independent Director	1.8yrs	US$233.01k	0.10% $ 103.4k
Adam Arkin	Member of Scientific Advisory Board	no data	geen gegevens	geen gegevens

3.3yrs

Gemiddelde duur

59yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van CELL wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

PhenomeX Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

High number of new directors

Berkeley Lights, Inc. Announces Appointment of Scott Chaplin as Chief Legal Officer and Corporate Secretary

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Recent updates

Bruker Cellular Analysis, Inc. Files Form 15

Phenomex Announces Opto Memory B Discovery Human Workflow on the Beacon®? Optofluidic Platform

PhenomeX Inc. Announces the Release of SpotLight™ Human Lambda Reagent for the Beacon® Platform to Accelerate Cell Line Development Workflows

Phenomex Unveils Meteor Chips for Quantitative Bulk Analysis on the Isospark™ Platform to Revolutionize High Throughput Multiplexed Hands-Free Proteomics

Consensus EPS estimates upgraded to US$1.13 loss

Consensus EPS estimates fall by 22%

Price target decreased by 29% to US$4.00

Bruker Corporation (NasdaqGS:BRKR) signed a definitive agreement to acquire all of the outstanding shares of PhenomeX Inc. (NasdaqGS:CELL).

New major risk - Share price stability

New major risk - Financial position

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

PhenomeX Inc. to Report Q2, 2023 Results on Aug 14, 2023

PhenomeX Inc. Announces Lifting of the Stay in AbCellera Patent Infringement Case

PhenomeX Inc.(NasdaqGS:CELL) dropped from Russell Small Cap Comp Value Index

PhenomeX Receives a Notice from Nasdaq Regarding Minimum Bid Price Rule

PhenomeX Inc. Launches Beacon Quest™? Optofluidic System with Opto®? T Cell Profiling Workflows

Price target decreased by 31% to US$5.67

Consensus revenue estimates decrease by 16%, EPS upgraded

PhenomeX Inc. Launches Beacon Select Optofluidic System with Opto B Discovery Workflows

Analyst Forecasts Just Became More Bearish On PhenomeX Inc. (NASDAQ:CELL)

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

PhenomeX Inc. Provides Earning Guidance for the Full Year of 2023

PhenomeX Inc.'s (NASDAQ:CELL) Subdued P/S Might Signal An Opportunity

Full year 2022 earnings: EPS and revenues miss analyst expectations

Berkeley Lights, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Berkeley Lights, Inc. Provides Preliminary Revenue Guidance for the Year Ended December 31, 2022

Berkeley Lights, Inc. (NasdaqGS:BLI) announced a definitive agreement to acquire IsoPlexis Corporation (NasdaqGS:ISO) from a group of shareholders for $56.3 million.

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

High number of new directors

Third quarter 2022 earnings: EPS misses analyst expectations

Berkeley Lights, Inc. Provides Revenue Guidance for the Year 2022

Berkeley Lights, Inc. to Report Q3, 2022 Results on Nov 08, 2022

Berkeley Lights, Inc. Announces Appointment of Scott Chaplin as Chief Legal Officer and Corporate Secretary

CEO & Director notifies of intention to sell stock

President of Global Operations notifies of intention to sell stock

Consensus revenue estimates fall by 17%

Analysts Just Made A Major Revision To Their Berkeley Lights, Inc. (NASDAQ:BLI) Revenue Forecasts

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Berkeley Lights, Inc. Provides Revenue Guidance for the Full Year 2022

Berkeley Lights, Inc. and the Jaime Leandro Foundation Announce the Discovery, Functional Characterization, and Recovery of A Patient-Derived T Cell Receptor Sequence Against A Cancer Neoantigen

Berkeley Lights, Inc. Announces Appointment of Dr. Rolando Brawer as Executive Vice President, Strategy & Corporate Development

Berkeley Lights Inc. Announces Mehul Joshi as New Chief Financial Officer

Mehul Joshi joins Berkeley Lights as CFO

Berkeley Lights, Inc. to Report Q2, 2022 Results on Aug 09, 2022

Insider notifies of intention to sell stock

First quarter 2022 earnings: EPS misses analyst expectations

Price target decreased to US$16.80

High number of new directors

Berkeley Lights, Inc., Annual General Meeting, May 26, 2022

Berkeley Lights Announces Appointment of Lucas S. Vitale as Chief Human Resources Officer

Insider recently bought US$502k worth of stock

Berkeley Lights, Inc. Releases Upgrade to Its Software Suite for Beacon and Lightning Platforms

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Berkeley Lights, Inc. Reiterates Revenue Guidance for Full Year 2022

Price target decreased to US$30.40

Berkeley Lights, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Berkeley Lights, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case

ClaimsFiler Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Berkeley Lights, Inc

High number of new directors

Berkeley Lights, Inc. Provides Revenue Guidance for Full Year of 2021 and 2022

Berkeley Lights, Inc. to Showcase its Optofluidic Discovery Technology At 2021 Antibody Engineering & Therapeutics Conference

Berkeley Lights Grows Revenue But Operating Losses Mount

Robbins Geller Rudman & Dowd LLP Files Class Action Suit Against Berkeley Lights, Inc

Independent Chairman of the Board recently bought US$500k worth of stock

Are Investors Undervaluing Berkeley Lights, Inc. (NASDAQ:BLI) By 49%?

Third quarter 2021 earnings released: US$0.30 loss per share (vs US$0.16 loss in 3Q 2020)

Berkeley Lights: Short Seller Report Raises A Few Legitimate Questions